Donna Sullivan is patient advocate, medical educator, writer, film producer, speaker and the proud mom of three kids navigating life with Ehlers Danlos Syndrome. As a trailblazing health advocate, Donna has spent over a decade working to raise awareness of the unique access to care challenges faced by families dealing with Ehlers-Danlos Syndrome, complex pain conditions, and rare diseases. After 9 years, Donna is proud to be releasing a feature length documentary film, Complicated, which she co-produced with Oscar shortlisted film Director Andrew Abrahams of Open Eye Pictures. This film premiered at the prestigious Slamdance film festival in February 2025 and will be released later this year. Complicated seeks to raise awareness of the seriousness of Ehlers Danlos Syndrome and give voice to a young population of patients impacted by the challenges that this historically misunderstood, underfunded and mistreated genetic condition has created for both patients and healthcare providers. Donna has recently co founded Elevate Rare, a patient led non profit whose mission is to raise awareness of harmful care gaps in rare disease. For the past twelve years, Donna has volunteered as a board member for The Coalition Against Pediatric Pain. She is also the Director of Patient Advocacy for Pathways to Trust, a non-profit that educates healthcare providers and medical students about the unmet needs of marginalized patient populations. She's serves on the board for the researched based Connective Tissue Coalition, and she is on the advisory board for the new nursing program at her alma mater, Providence College. Donna is also a member of the EDS Society AHEAD Coalition.
Industry partners recognize the need to learn from patient and caregiver's stories of their lived experience. Patient and caregiver stories are the heart of rare disease insights. Patients and caregivers have created authentic, compelling media - from blogs to podcasts to films - offering an invaluable window into the rare disease experience. Tapping into the emerging and increasingly robust media environment specific to rare disease stories can be a first step for patient engagement. Storytelling isn't just advocacy and it can be a key asset to industry supporting and developing meaningful relationships with these creators - who have the pulse of the community. Publicly available and searchable sources of rare disease patient stories represent an under-utilized opportunity for industry. The panel will outline ways industry can make use of these media outlets as part of their social listening and pre-engagement plans to set themselves up for more meaningful connection, and authentic engagement.